Core Viewpoint - The company, Weining Health, announced that it will not adjust the conversion price of its convertible bonds despite triggering conditions for a downward adjustment due to stock price performance [1] Summary by Relevant Sections Company Announcement - As of November 10, 2025, Weining Health's stock price has closed below 85% of the current conversion price (17.31 CNY/share) for 15 out of the last 30 trading days, triggering the downward adjustment clause for its convertible bonds [1] - The company's board of directors held a meeting on November 10, 2025, and approved a resolution not to adjust the conversion price of the "Weining Convertible Bonds" [1] - The decision means that for the next three months (from November 11, 2025, to February 10, 2026), if the conditions for a downward adjustment are triggered again, the company will not propose an adjustment [1] Future Considerations - The next period for potential triggering of the conversion price adjustment will restart from February 11, 2026, and if conditions are met, the company will follow the necessary procedures to decide on any potential adjustment [1]

Core Viewpoint - The article discusses various convertible bonds, their current prices, redemption prices, last trading dates, conversion values, remaining scales, and their proportion to the underlying stocks, highlighting the investment landscape for these financial instruments [1][3][5]. Group 1: Convertible Bonds Overview - Wei Ning Convertible Bond (卫宁转债) will not undergo adjustments, with the last trading day set for December 9, 2025 [1]. - The Z Tong Cheng Convertible Bond (Z彤程转) has a current price of 125.708, with a redemption price of 101.440 and a conversion value of 126.17 [3]. - The Z Sheng 24 Convertible Bond (Z升24转) is priced at 113.184, with a redemption price of 100.168 and a conversion value of 113.67 [3]. - The Luo Kai Convertible Bond (洛凯转债) is currently at 126.615, with a redemption price of 100.038 and a conversion value of 125.05 [3]. - The Chen Feng Convertible Bond (晨丰转债) has a current price of 161.169, with a redemption price of 100.616 and a conversion value of 161.39 [3]. - The Zhong Jin Convertible Bond (中金转债) is priced at 126.333, with a redemption price of 100.700 and a conversion value of 126.81 [3]. - The Heng Bang Convertible Bond (恒邦转债) is currently at 122.680, with a redemption price of 100.280 and a conversion value of 122.79 [3]. - The Qi Bin Convertible Bond (旗滨转债) has a current price of 125.607, with the last trading day yet to be announced and a conversion value of 126.15 [3]. Group 2: Additional Convertible Bonds Information - The Feng Huo Convertible Bond (烽火转债) is priced at 110.722, with a redemption price of 106.000 and a conversion value of 111.15 [5]. - The Eagle 19 Convertible Bond (鹰19转债) has a current price of 116.589, with a redemption price of 111.000 and a conversion value of 103.41 [5]. - The Hong Da Convertible Bond (鸿达退债) is priced at 12.556, with a redemption price of 118.000 and a conversion value of 3.07 [5].

Core Viewpoint - The announcement from Weining Health indicates that the company's stock price has fallen below 85% of the current conversion price, potentially triggering a downward adjustment of the convertible bond conversion price [2] Group 1 - As of the announcement date, the company's stock has closed below 14.71 yuan per share for 10 trading days, which is 85% of the current conversion price of 17.31 yuan per share [2] - If the conditions for adjusting the conversion price are met, the company will convene a board meeting on the triggering day to decide whether to adjust the conversion price and will fulfill its information disclosure obligations promptly [2]

Core Viewpoint - The article discusses the recent issuance of new stocks on the Beijing Stock Exchange, highlighting the significant subscription funds amounting to over 600 billion [1]. Group 1 - Fourhui Fushi's controlling shareholder plans to reduce holdings by no more than 3% of the company's shares [2]. - Huiyun Titanium's controlling shareholder intends to reduce holdings by no more than 2.98% of the company's shares [2]. - Yong'an Convertible Bond is subject to strong redemption [2]. Group 2 - Baichuan Co., Ltd.'s actual controller has been performing duties normally [2]. - Haining Convertible Bond and Honglu Convertible Bond will not undergo adjustments [2]. - Yinxin Convertible Bond and Jingyuan Convertible Bond will not face strong redemption [2]. Group 3 - Dingjia Precision's new stock on the Beijing Stock Exchange is available for subscription on July 22 [2]. - Hanghai Group is involved in new stock subscriptions on the Shanghai and Shenzhen exchanges [2].

Core Viewpoint - The company announced the results of the convertible bond repurchase, indicating that no bonds were repurchased during the designated period, which will not significantly impact its financial status or operational capabilities [1][2]. Group 1: Announcement of Convertible Bond Repurchase - The company published multiple announcements regarding the repurchase of its convertible bonds, allowing holders to sell their bonds back to the company at a price of 100.281 CNY per bond, including interest and tax [1][2]. - The repurchase period was specified to end on May 16, 2025, after which the company would not need to process any payments to bondholders [2]. Group 2: Repurchase Results and Impact - The total number of valid repurchase applications for the "卫宁转债" was reported as 0, resulting in a repurchase amount of 0 CNY [2]. - The company stated that the lack of repurchase will not have a significant effect on its financial condition, operational results, cash flow, or capital structure, and it will not impair its debt servicing ability or ongoing operations [2].

Summary of Key Points Core Viewpoint - The company, Weining Health Technology Group Co., Ltd., has announced the conditional redemption of its convertible bonds ("Weining Convertible Bonds") due to the stock price falling below a specified threshold, allowing bondholders to sell their bonds back to the company at a predetermined price [1][4]. Group 1: Redemption Conditions - The redemption condition is triggered when the company's stock price remains below 70% of the current conversion price of 17.45 CNY per share, which is 12.22 CNY per share, for thirty consecutive trading days [1][2]. - The redemption period is set from March 16, 2025, to April 28, 2025, during which bondholders can exercise their right to redeem their bonds [1][5]. Group 2: Redemption Price Calculation - The calculated redemption price for the Weining Convertible Bonds is 100.281 CNY per bond, which includes accrued interest [4]. - The interest rate for the bonds is set at 1.8%, and the accrued interest for the period from March 16, 2025, to May 12, 2025, is calculated to be 0.281 CNY per bond [3][4]. Group 3: Tax Implications - Individual investors and securities investment funds will have a 20% withholding tax on interest income, resulting in a net redemption amount of 100.225 CNY per bond [4]. - Qualified foreign institutional investors (QFII and RQFII) are exempt from income tax, receiving the full redemption amount of 100.281 CNY per bond [4]. Group 4: Redemption Process - The company will announce the redemption details on the trading day following the fulfillment of the redemption conditions and will provide daily updates until the end of the redemption period [5]. - Bondholders must submit their redemption requests between May 12, 2025, and May 21, 2025, and once confirmed, these requests cannot be revoked [5]. Group 5: Trading During Redemption Period - The Weining Convertible Bonds will continue to trade during the redemption period, but conversion to stock will be suspended [5].